GENERAL17 Sept 2026
Govt tightens stem cell therapy rules, bars routine use for autism
The government has tightened stem cell therapy rules. For autism, the ministry says therapeutic use of any type of stem cell stays limited to duly approved clinical trials. This affects clinics, doctors and families considering such treatment. In practice, routine stem cell therapy for autism is no longer allowed outside approved trials. So check trial approvals before advising or offering it as routine care.
Key Statutory Highlights
- For autism, therapeutic use of any type of stem cell will remain restricted to duly approved clinical trials.
- Stem cell therapy is a treatment that uses stem cells to replace, repair or regenerate damaged or diseased cells, tissues or organs.
- The government has tightened stem cell therapy rules and barred routine use for autism.
Actionable Advice for Taxpayers / Founders:If you run a clinic or advise patients, avoid presenting stem cell therapy for autism as routine treatment, and confirm whether a duly approved clinical trial covers the case before recommending it.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: